These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28124878)

  • 21. Venous thromboembolism and cancer: pathophysiology and incidence.
    Stricker H
    Vasa; 2014 Jul; 43(4):239-43. PubMed ID: 25007901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of extended postoperative venous thromboembolism prophylaxis in IBD: a National Surgical Quality Improvement Program analysis.
    Gross ME; Vogler SA; Mone MC; Sheng X; Sklow B
    Dis Colon Rectum; 2014 Apr; 57(4):482-9. PubMed ID: 24608305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboembolism After Intramedullary Nailing for Metastatic Bone Lesions.
    Shallop B; Starks A; Greenbaum S; Geller DS; Lee A; Ready J; Merli G; Maltenfort M; Abraham JA
    J Bone Joint Surg Am; 2015 Sep; 97(18):1503-11. PubMed ID: 26378266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management of thromboembolic risk in patients with cancer].
    Trujillo Santos AJ
    Med Clin (Barc); 2012 Oct; 139 Suppl 2():31-5. PubMed ID: 23498070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.
    Pangilinan JM
    J Pharm Pract; 2010 Aug; 23(4):294-302. PubMed ID: 21507829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse impact of venous thromboembolism on patients with cancer.
    Arora M; Wun T
    Semin Thromb Hemost; 2014 Apr; 40(3):313-8. PubMed ID: 24599435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The assessment of thrombotic risk using a predictive model in metastatic cancer patients undergoing first-line therapy.
    Kim SY; Burns ZT; Henry DH
    Thromb Res; 2012 Dec; 130(6):967-70. PubMed ID: 23036533
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk of venous thromboembolic events following inferior vena cava resection and reconstruction.
    Hicks CW; Glebova NO; Piazza KM; Orion K; Pierorazio PM; Lum YW; Abularrage CJ; Black JH
    J Vasc Surg; 2016 Apr; 63(4):1004-10. PubMed ID: 26597664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous sex hormone levels in men with unprovoked deep-vein thrombosis.
    Mumoli N; Cei M; Giorgi Pierfranceschi M; Brondi B; Vitale J; Dentali F
    Thromb Haemost; 2015 Aug; 114(2):438-9. PubMed ID: 25904438
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary thromboprophylaxis in hospices: the association between risk of venous thromboembolism and development of symptoms.
    Johnson MJ; McMillan B; Fairhurst C; Gabe R; Ward J; Wiseman J; Pollington B; Noble SI
    J Pain Symptom Manage; 2014 Jul; 48(1):56-64. PubMed ID: 24331547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis and prophylaxis of venous thromboembolic complications at large ventral hernias].
    Lubianskiĭ VG; Kolobova OI; Onoshkin VV; Kostina IuP
    Khirurgiia (Mosk); 2008; (1):30-2. PubMed ID: 18427468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database.
    Fleming FJ; Kim MJ; Salloum RM; Young KC; Monson JR
    Dis Colon Rectum; 2010 Oct; 53(10):1355-60. PubMed ID: 20847615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation.
    Riva N; Donadini MP; Ageno W
    Thromb Haemost; 2015 Jun; 113(6):1176-83. PubMed ID: 25472800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of venous thrombosis.
    López JA; Chen J
    Thromb Res; 2009; 123 Suppl 4():S30-4. PubMed ID: 19303501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overweight, obesity, and the risk of recurrent venous thromboembolism.
    Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
    Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients.
    Ferroni P; Martini F; Portarena I; Grenga I; Riondino S; La Farina F; Laudisi A; Roselli M; Guadagni F
    Thromb Haemost; 2011 May; 105(5):931-2. PubMed ID: 21359410
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of body mass index on outcomes after major resection for cancer.
    Zogg CK; Mungo B; Lidor AO; Stem M; Rios Diaz AJ; Haider AH; Molena D
    Surgery; 2015 Aug; 158(2):472-85. PubMed ID: 26008961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for cancer-associated venous thromboembolism in outpatient deep venous thrombosis clinics.
    Rose P; McManus A; Arya R; Scriven N; Farren T; Nokes T; Bacon S; Cooper D; O'Shaughnessy D; Paneesha S
    Br J Haematol; 2010 Sep; 150(5):640-1. PubMed ID: 20560972
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessing risk and mortality of venous thromboembolism in pancreatic cancer patients.
    Shaib W; Deng Y; Zilterman D; Lundberg B; Saif MW
    Anticancer Res; 2010 Oct; 30(10):4261-4. PubMed ID: 21036750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system.
    Yu YB; Gau JP; Liu CY; Yang MH; Chiang SC; Hsu HC; Hong YC; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Lee TS; Chou LF; Tzeng CH; Chen TJ
    Thromb Haemost; 2012 Aug; 108(2):225-35. PubMed ID: 22534880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.